T1	Participants 0 191	Intense androgen-deprivation therapy with abiraterone acetate plus leuprolide acetate in patients with localized high-risk prostate cancer: results of a randomized phase II neoadjuvant study.
T2	Participants 975 1117	PATIENTS AND METHODS A neoadjuvant randomized phase II trial of LHRHa with AA was conducted in patients with localized high-risk PCa (N = 58).
T3	Participants 1118 1204	For the first 12 weeks, patients were randomly assigned to LHRHa versus LHRHa plus AA.
T4	Participants 1205 1324	After a research prostate biopsy, all patients received 12 additional weeks of LHRHa plus AA followed by prostatectomy.
